4th Quarter - Report

EPILEPSY FOUNDATION for EPILEPSY FOUNDATION

Firm
Client
Income
—
Expenses
$60,000
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Civil Rights/Civil Liberties CIV

-H.R. 1549, Air Carrier Access Amendments Act, support passage to make air travel more accessible for people with disabilities

LobbyistCovered position, as disclosed
RACHEL PATTERSON —

Contacted: Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1549 (116th)

Health Issues HCR

-H.R. 2279/S. 2546, Safe Step Act, support passage -H.R. 3, Elijah Cummings Lower Drug Costs Now Act, support specific provisions such as an out-of-pocket cap in Medicare Part D and addition of language to ban the use of QALYs -HR 3630, the No Surprises Act; S 1895, the S. 1895, Lower Health Care Costs Act; S 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019, support passage of legislation to protect patients from surprise medical billing that holds patients harmless -S. 2543, the Prescription Drug Pricing Reduction Act of 2019, support specific provisions such as an out-of-pocket cap in Medicare and improvements to the Medicaid Drug Rebate Program. -S. 1895, Lower Health Care Costs Act, support provisions to increase transparency and address anticompetitive practices in the prescription drug market -H.R. 712, VA Medicinal Cannabis Research Act, support addition of epilepsy -H.R. 2093/S. 1028, STATES Act, support passage -H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage -H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage -FDA-2019-N-1428, Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds, support preservation of meaningful access to cannabis and cannabis-derived products, including CBD tinctures with therapeutic levels of the cannabinoid, and creation of a regulatory framework that ensures that there is consistency in available products, manufacturing, safety, testing, and labeling standards, and increases the availability of important information such as potential side effects and drug interactions so that consumers and practitioners may be better informed -H.R. 2035/S. 995, Lifespan Respite Reauthorization Act, support passage.

LobbyistCovered position, as disclosed
RACHEL PATTERSON —
ABBEY ROUDEBUSH —
LAURA WEIDNER —

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); SENATE

Bills named: S. 995 (116th), H.R. 2279 (116th), H.R. 4322 (116th), S. 1028 (116th), S. 2400 (116th), H.R. 3630 (116th), H.R. 127 (116th), H.R. 3 (116th), H.R. 712 (116th), S. 1895 (116th), H.R. 2035 (116th), H.R. 2093 (116th), S. 2546 (116th), S. 2543 (116th)

Budget/Appropriations BUD

-H.R. 4378, Continuing Appropriations Act, 2020, and Health Extenders Act of 2019, support passage. -H.R. 3055, Further Continuing Appropriations Act, 2020, and Further Health Extenders Act of 2019, support passage. -H.R. 1865, Further Consolidated Appropriations Act, 2020, support passage including supporting specific provisions including $9.5 million for the CDCs Epilepsy program, $41.7 billion for the NIH, $3.16 billion for the FDA, 10 year reauthorization of the Patient-Centered Outcomes Research Institute (PCORI) and 5 month extension of Money Follows the Person and spousal impoverishment.

LobbyistCovered position, as disclosed
RACHEL PATTERSON —
ABBEY ROUDEBUSH —
LAURA WEIDNER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS)

Bills named: H.R. 4378 (116th), H.R. 1865 (116th), H.R. 3055 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.